HealthTechMovers.com has identified several healthtech stocks which are expected to go “Ex-Dividend” very soon. Remember, if you purchase a stock on its ex-dividend date or after, you will not receive the next dividend payment. Instead, the seller gets the dividend. If you purchase before the ex-dividend date, you get the dividend.
PoliticsAndMyPortfolio.com is looking into these tickers DAWN, MTDR, AVY, CMC, MNST, RTX and more.
If you sell your stock before the ex-dividend date, you also are selling away your right to the stock dividend.
So please keep this in mind.
Below is our latest Dividend Report:
Bio-Techne
Symbol: TECH
Recent TECH Price: $78.44
Average Analyst Price Target: $102.80 (31.06%)
TECH Market Cap: $12.43B
Expected Ex-Dividend Date for TECH stock: Feb 10 2023
Expected Payment Date for TECH stock: Feb 27 2023
Expected Dividend & Yield for TECH stock: 0.40%
Recent Analyst Action: Conor McNamara, analyst at RBC Capital, reiterates coverage on Bio-Techne (TECH) stock in the Healthcare sector with a Hold rating and a price target of $ 88 (1 day ago).
Click for full story on TECH stock >>--------------------------------------------------------------------------
Iradimed
Symbol: IRMD
Recent IRMD Price: $37.35
Average Analyst Price Target: $49.50 (32.53%)
IRMD Market Cap: $518.49M
Expected Ex-Dividend Date for IRMD stock: Feb 10 2023
Expected Payment Date for IRMD stock: Feb 21 2023
Expected Dividend & Yield for IRMD stock:
Recent Analyst Action: Scott Henry, analyst at Roth Capital, reiterates coverage on Iradimed (IRMD) stock in the Healthcare sector with a Buy rating and a price target of $ 48 (1 day ago).
Click for full story on IRMD stock >>--------------------------------------------------------------------------
PoliticsAndMyPortfolio.com keeps our subscribers informed of breaking news, reports, stock news or information that can have a positive or negative impact on their portfolio. We look at world events, political activity and the movement of stocks, bonds, metals, commodities and more to provide investors with timely information. Join thousands of investors who already signed up for our free subscription to PoliticsAndMyPortfolio.com.
